The long-term course of fatigue following breast cancer diagnosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The long-term course of fatigue following breast cancer diagnosis. / Biering, Karin; Frydenberg, Morten; Pappot, Helle; Hjollund, Niels Henrik.

I: Journal of Patient-Reported Outcomes, Bind 4, 37, 2020.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Biering, K, Frydenberg, M, Pappot, H & Hjollund, NH 2020, 'The long-term course of fatigue following breast cancer diagnosis', Journal of Patient-Reported Outcomes, bind 4, 37. https://doi.org/10.1186/s41687-020-00187-9

APA

Biering, K., Frydenberg, M., Pappot, H., & Hjollund, N. H. (2020). The long-term course of fatigue following breast cancer diagnosis. Journal of Patient-Reported Outcomes, 4, [37]. https://doi.org/10.1186/s41687-020-00187-9

Vancouver

Biering K, Frydenberg M, Pappot H, Hjollund NH. The long-term course of fatigue following breast cancer diagnosis. Journal of Patient-Reported Outcomes. 2020;4. 37. https://doi.org/10.1186/s41687-020-00187-9

Author

Biering, Karin ; Frydenberg, Morten ; Pappot, Helle ; Hjollund, Niels Henrik. / The long-term course of fatigue following breast cancer diagnosis. I: Journal of Patient-Reported Outcomes. 2020 ; Bind 4.

Bibtex

@article{a2e384b8703946fa85d704eb3380a051,
title = "The long-term course of fatigue following breast cancer diagnosis",
abstract = "Purpose: Fatigue following breast cancer is a well-known problem, with both high and persistent prevalence. Previous studies suffer from lack of repeated measurements, late recruitment and short periods of follow-up. The course of fatigue from diagnosis and treatment to the long-time outcome status is unknown as well as differences in the level of fatigue between treatment regimens. The purpose of this study was to describe the long-time course of fatigue from the time of clinical suspicion of breast cancer, its dependence of patient characteristics and treatment regimens and the comparison with the course of fatigue among women with the same suspicion, but not diagnosed with breast cancer. Methods: Three hundred thirty-two women referred to acute or subacute mammography was followed with questionnaires from before the mammography and up to 1500 days. Fatigue was measured by the Multidimensional Fatigue Inventory (MFI-20). The women reported their initial level of fatigue before the mammography and thus without knowledge of whether they had cancer or not. Both women with and without cancer were followed. Women with cancer were identified in the clinical database established by Danish Breast Cancer Cooperative Group (DBCG) to collect information on treatment regimen. Results: Compared to fatigue scores before diagnosis, women with breast cancer reported a large increase of fatigue, especially in the first 6 months, followed by a slow decrease over time. Despite the long follow-up period, the women with breast cancer did not return to their level of fatigue at time of the mammography. Women without breast cancer, experienced a rapid decrease of fatigue after disproval of diagnosis followed by a steadier period. Conclusions: Fatigue is a persistent problem in women diagnosed with breast cancer, even several years following diagnosis and treatment. The women with breast cancer were most affected by fatigue in the first 6 months after diagnosis.",
keywords = "Breast Cancer, Fatigue, Long-term, Longitudinal, Mammography, Rehabilitation",
author = "Karin Biering and Morten Frydenberg and Helle Pappot and Hjollund, {Niels Henrik}",
year = "2020",
doi = "10.1186/s41687-020-00187-9",
language = "English",
volume = "4",
journal = "Journal of Patient-Reported Outcomes",
issn = "2509-8020",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - The long-term course of fatigue following breast cancer diagnosis

AU - Biering, Karin

AU - Frydenberg, Morten

AU - Pappot, Helle

AU - Hjollund, Niels Henrik

PY - 2020

Y1 - 2020

N2 - Purpose: Fatigue following breast cancer is a well-known problem, with both high and persistent prevalence. Previous studies suffer from lack of repeated measurements, late recruitment and short periods of follow-up. The course of fatigue from diagnosis and treatment to the long-time outcome status is unknown as well as differences in the level of fatigue between treatment regimens. The purpose of this study was to describe the long-time course of fatigue from the time of clinical suspicion of breast cancer, its dependence of patient characteristics and treatment regimens and the comparison with the course of fatigue among women with the same suspicion, but not diagnosed with breast cancer. Methods: Three hundred thirty-two women referred to acute or subacute mammography was followed with questionnaires from before the mammography and up to 1500 days. Fatigue was measured by the Multidimensional Fatigue Inventory (MFI-20). The women reported their initial level of fatigue before the mammography and thus without knowledge of whether they had cancer or not. Both women with and without cancer were followed. Women with cancer were identified in the clinical database established by Danish Breast Cancer Cooperative Group (DBCG) to collect information on treatment regimen. Results: Compared to fatigue scores before diagnosis, women with breast cancer reported a large increase of fatigue, especially in the first 6 months, followed by a slow decrease over time. Despite the long follow-up period, the women with breast cancer did not return to their level of fatigue at time of the mammography. Women without breast cancer, experienced a rapid decrease of fatigue after disproval of diagnosis followed by a steadier period. Conclusions: Fatigue is a persistent problem in women diagnosed with breast cancer, even several years following diagnosis and treatment. The women with breast cancer were most affected by fatigue in the first 6 months after diagnosis.

AB - Purpose: Fatigue following breast cancer is a well-known problem, with both high and persistent prevalence. Previous studies suffer from lack of repeated measurements, late recruitment and short periods of follow-up. The course of fatigue from diagnosis and treatment to the long-time outcome status is unknown as well as differences in the level of fatigue between treatment regimens. The purpose of this study was to describe the long-time course of fatigue from the time of clinical suspicion of breast cancer, its dependence of patient characteristics and treatment regimens and the comparison with the course of fatigue among women with the same suspicion, but not diagnosed with breast cancer. Methods: Three hundred thirty-two women referred to acute or subacute mammography was followed with questionnaires from before the mammography and up to 1500 days. Fatigue was measured by the Multidimensional Fatigue Inventory (MFI-20). The women reported their initial level of fatigue before the mammography and thus without knowledge of whether they had cancer or not. Both women with and without cancer were followed. Women with cancer were identified in the clinical database established by Danish Breast Cancer Cooperative Group (DBCG) to collect information on treatment regimen. Results: Compared to fatigue scores before diagnosis, women with breast cancer reported a large increase of fatigue, especially in the first 6 months, followed by a slow decrease over time. Despite the long follow-up period, the women with breast cancer did not return to their level of fatigue at time of the mammography. Women without breast cancer, experienced a rapid decrease of fatigue after disproval of diagnosis followed by a steadier period. Conclusions: Fatigue is a persistent problem in women diagnosed with breast cancer, even several years following diagnosis and treatment. The women with breast cancer were most affected by fatigue in the first 6 months after diagnosis.

KW - Breast Cancer

KW - Fatigue

KW - Long-term

KW - Longitudinal

KW - Mammography

KW - Rehabilitation

U2 - 10.1186/s41687-020-00187-9

DO - 10.1186/s41687-020-00187-9

M3 - Journal article

C2 - 32424569

AN - SCOPUS:85084985000

VL - 4

JO - Journal of Patient-Reported Outcomes

JF - Journal of Patient-Reported Outcomes

SN - 2509-8020

M1 - 37

ER -

ID: 255838409